Pfizer acquires Wyeth: New Pfizer Poultry Health

A new Pfizer Poultry Health has been unveiled as Pfizer's global acquisition of Wyeth, and its subsidiary Wyeth / Fort Dodge Animal Health, was completed.

The acquisition allows Pfizer Poultry Health, a unit of Pfizer Animal Health, to strengthen its position as a leader in the discovery, development and manufacturing of devices and vaccines for the global poultry industry.

Fort Dodge brings an estimated 85 poultry products to those already available from Pfizer Poultry Health, resulting in a truly diversified product portfolio that is backed by unrivalled expertise and customer support.

“This is a landmark occasion for Pfizer Poultry Health, which now includes even more best-in-class and innovative products,” said Joyce Lee, VP, Pfizer Poultry Health. “The products, services and expertise we are gaining strengthen what is already an exceptional in ovo portfolio and will enhance our leadership position in the poultry marketplace.”

Prices and policies

Pfizer Poultry Health has also announced that all current pricing, product distribution, programmes and policies for Pfizer Poultry Health products, including the acquired Fort Dodge products, will remain in place through 2009.

“In the years ahead, Pfizer Poultry Health plans to become more than just a world leader of in ovo technology,” Lee said. “We will work to ensure customers continue to receive the same high level of service they have come to expect from Pfizer and Fort Dodge. We envision a future where veterinarians, hatchery managers, and poultry producers look to Pfizer Poultry Health first for optimal solutions to their poultry health needs, supported by an expansive product portfolio.”

Or register to be able to comment.